Thrivent Financial for Lutherans Has $2.98 Million Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Thrivent Financial for Lutherans raised its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 48.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,756 shares of the company's stock after purchasing an additional 12,348 shares during the quarter. Thrivent Financial for Lutherans' holdings in GE HealthCare Technologies were worth $2,978,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of GEHC. State Street Corp grew its stake in shares of GE HealthCare Technologies by 7.8% in the 3rd quarter. State Street Corp now owns 18,615,890 shares of the company's stock valued at $1,747,101,000 after buying an additional 1,347,114 shares in the last quarter. Geode Capital Management LLC grew its position in GE HealthCare Technologies by 7.2% in the third quarter. Geode Capital Management LLC now owns 10,977,757 shares of the company's stock worth $1,026,898,000 after acquiring an additional 733,819 shares in the last quarter. Van ECK Associates Corp grew its position in GE HealthCare Technologies by 107.3% in the fourth quarter. Van ECK Associates Corp now owns 4,841,652 shares of the company's stock worth $378,520,000 after acquiring an additional 2,506,417 shares in the last quarter. Bank of New York Mellon Corp increased its stake in shares of GE HealthCare Technologies by 11.2% during the 4th quarter. Bank of New York Mellon Corp now owns 3,476,586 shares of the company's stock worth $271,800,000 after purchasing an additional 349,539 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of GE HealthCare Technologies by 9.2% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,959,256 shares of the company's stock valued at $231,355,000 after purchasing an additional 248,318 shares in the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the stock. Citigroup upped their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a report on Thursday, February 13th. Jefferies Financial Group raised GE HealthCare Technologies from a "hold" rating to a "buy" rating and upped their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Wells Fargo & Company lifted their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research report on Friday, February 14th. Finally, The Goldman Sachs Group raised shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $85.00 to $100.00 in a report on Tuesday, March 11th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $98.75.

GE HealthCare Technologies Stock Performance

Shares of GEHC traded down $1.65 during trading hours on Friday, reaching $80.01. 3,189,762 shares of the company traded hands, compared to its average volume of 2,933,671. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The stock's fifty day moving average is $86.70 and its 200 day moving average is $85.86. GE HealthCare Technologies Inc. has a 1-year low of $74.51 and a 1-year high of $94.80. The stock has a market cap of $36.59 billion, a P/E ratio of 18.48, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be given a $0.035 dividend. The ex-dividend date is Friday, April 25th. This represents a $0.14 annualized dividend and a yield of 0.17%. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 3.23%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.